Journal
PHARMACOLOGICAL REPORTS
Volume 69, Issue 3, Pages 409-418Publisher
SPRINGER HEIDELBERG
DOI: 10.1016/j.pharep.2016.12.005
Keywords
Leptin; Glial cells; iNOS; p38 MAPK; Caspase-3; Cytochrome-c
Categories
Funding
- Generalitat de Catalunya (autonomous government of Catalonia) [2009/SGR00853]
- Spanish Ministerio de Ciencia e Innovacion [SAF2011-23631]
Ask authors/readers for more resources
Background: In the present work, we studied the modulatory effect of Leptin (Lep) against pro-inflammatory cytokines, tumour necrosis factor-alpha (TNF alpha), interleukin 1-beta (IL1 beta) and interferon-gamma (IFN gamma), in primary glial cell cultures. Methods: Glial cultures were treated with pro-inflammatory cytokines (TNF alpha, 20 ng/ml; IL1 beta, 20 ng/ml; IFN gamma 20 ng/ml). Cells were pre-treated with Lep 500 nM, 1 h prior to cytokine treatment. NO released from glial cells was determined using the Griess reaction. Cell viability was determined by the MTT method. Protein expression was determined by western blot. Results: Pre-treatment with 500 nM Lep produced an inhibitory effect on inducible nitric oxide synthase (iNOS) expression and nitric oxide (NO) production after glial cells exposure to pro-inflammatory cytokines. Anti-inflammatory effect can be related to a decrease in P38 MAP Kinase (MAPK) pathway activity. Treatment of glial cell cultures with Lep also reduced the intrinsic apoptotic pathway (cytochrome c release and caspase-3 activation). Conclusions: We suggest that Lep would act as an anti-inflammatory factor in glial cells exposed to pro-inflammatory cytokines, exerting its function on p38 MAPK pathway and reducing NO production. (C) 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Sp. z o.o. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available